HPV driven cancers, including HPV+ HNSCC, are characterized by defects in the DDR pathway, making them potentially susceptible to WEE1 inhibition. HPV+ cancers are those where the underlying cause is ...

An estimated 70% of the 20,000 cases of oropharyngeal squamous cell carcinoma (HNSCC ... agent APR-1051 in patients with advanced solid tumors harboring cancer-associated specific gene alterations.

Phase III IMvoke010 trial found that maintenance treatment with Tecentriq (atezolizumab) did not significantly improve survival compared with placebo in patients with locally advanced squamous cell ...

A patient with HPV-positive head and neck squamous cell carcinoma was dosed in a phase 1 clinical trial evaluating APR-1051.

Squamous cell cancer (SCC) is a type of skin cancer ... This does not mean SCC is not dangerous, though. The more advanced SCC becomes before doctors diagnose it, the more opportunity it has ...

Trisha Wise-Draper, MD, PhD, discusses anticipated data on head and neck cancers and their potential impact on the field.

Phase 2 trial results support further development of neoadjuvant nivolumab-based CIT and adaptive de-escalation of CRT in patients with locoregionally advanced HNSCC, according to researchers.

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...

Real Housewives of Beverly Hills alum Teddi Mellencamp shared more bad news amid her ongoing battle with cancer as doctors found new tumors that are Stage 4.